AI for Drug Development and Discovery Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Accelerated Drug Discovery Process
   3. Market Restraints
      1. High Implementation Costs
      2. Data Privacy and Security Concerns
   4. Market Opportunity
      1. Growing Demand for Personalized Medicine
   5. Market Trends
      1. Increased Collaboration Between Pharma Companies and AI Start-ups
      2. Adoption of AI-Powered Drug Repurposing
5. MARKET SEGMENTATION
   1. By Offering
      1. Software
      2. Services
   2. By Technology
      1. Machine Learning
         1. Deep Learning
         2. Supervised Learning
         3. Unsupervised Learning
         4. Reinforcement Learning
         5. Other Machine Learning Technologies
      2. Context-Aware Processing
      3. Natural Language Processing
      4. Others
   3. By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Metabolic Diseases
      5. Cardiovascular Diseases
      6. Immunology
      7. Other Therapeutic Areas
   4. By End Use
      1. Contract Research Organizations (CROs)
      2. Pharmaceutical and Biotechnology Companies
      3. Research Centers and Academic Institutes
      4. Others
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Aria Pharmaceuticals, Inc.
      2. Atomwise Inc.
      3. BIOAGE
      4. BenchSci
      5. BPGbio, Inc.
      6. BenevolentAI
      7. Celsius Therapeutics
      8. Cloud Pharmaceuticals
      9. CytoReason
      10. Deep Genomics, Inc.
      11. Exscientia
      12. Evaxion Biotech
      13. Envisagenics
      14. Iktos
      15. Insitro
      16. Illumina, Inc.
      17. IQVIA Inc
      18. Labcorp
      19. Microsoft Corporation
      20. NuMedii, Inc.
      21. Owkin, Inc.
      22. Predictive Oncology, Inc.
      23. Recursion
      24. Schrödinger, Inc
      25. Tempus Labs
      26. Verge Genomics
      27. Valo Health
      28. XtalPi Inc.
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global AI for Drug Development and Discoverymarket?

The global market of AI for Drug Development and Discovery is projected to reach USD26Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global AI for Drug Development and Discoverymarket?

The global AI for Drug Development and Discovery market has an estimated annual growth rate of 40.0%.

Q.3. What are the recent trends of AI for Drug Development and Discoverymarket?

Increased collaboration between pharma companies and AI start-ups and adoption of AI-powered drug repurposing are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in AI for Drug Development and Discovery?

The major companies profiled in this report include Aria Pharmaceuticals, Inc., Atomwise Inc., BIOAGE, BenchSci, BPGbio, Inc., BenevolentAI, Celsius Therapeutics, Cloud Pharmaceuticals, CytoReason, Deep Genomics, Inc., Exscientia, Evaxion Biotech, Envisagenics, Iktos, Insitro, Illumina, Inc., IQVIA Inc, Labcorp, Microsoft Corporation, NuMedii, Inc., Owkin, Inc., Predictive Oncology, Inc., Recursion, Schrödinger, Inc, Tempus Labs, Verge Genomics, Valo Health, XtalPi Inc., among others.   

Q.5. Which is the largest regional market in the AI for Drug Development and Discovery?

North America is the largest regional market for AI for Drug Development and Discovery.